Primary CNS lymphoma in patients younger than 60: Can whole-brain radiotherapy be deferred?

Journal of Neuro-Oncology

Volumn 104, Issue 1, 2011, Pages 323-330

  Omuro, Antonio ^a,b   Taillandier, Luc ^c   Chinot, Olivier ^d   Sierra Del Rio, Monica ^a   Carnin, Charlotte ^c   Barrie, Marylin ^d   Soussain, Carole ^e   Tanguy, Marie Laure ^a   Choquet, Sylvain ^a   Leblond, Veronique ^a   Hoang Xuan, Khe ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d TIMONE HOSPITAL   (France)

^e INSTITUT CURIE   (France)

Author keywords

Chemotherapy; Neurotoxicity; Primary central nervous system lymphoma; Radiotherapy

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; IDARUBICIN; IFOSFAMIDE; LOMUSTINE; METHOTREXATE; METHYLPREDNISOLONE; PROCARBAZINE; TEMOZOLOMIDE; THIOTEPA;

ADULT; ANEMIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN ABSCESS; BRAIN DISEASE; BRAIN RADIATION; CANCER COMBINATION CHEMOTHERAPY; CHEMOSENSITIVITY; DRUG ERUPTION; DRUG MEGADOSE; EPILEPTIC STATE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; HYPERGLYCEMIA; HYPONATREMIA; KARNOFSKY PERFORMANCE STATUS; LEUKOPENIA; LUNG DISEASE; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; OPTIC NERVE DISEASE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PROGRESSION FREE SURVIVAL; SALVAGE THERAPY; SEPTIC SHOCK; SPINAL CORD DISEASE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT PLANNING; TREATMENT REFUSAL; TREATMENT RESPONSE; WHOLE BRAIN RADIOTHERAPY;

ADULT; BRAIN; CENTRAL NERVOUS SYSTEM NEOPLASMS; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; DRUG THERAPY; FEMALE; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; YOUNG ADULT;

EID: 80052754538     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0497-x     Document Type: Article

References (37)

1. Omuro AM, Abrey LE (2006) Chemotherapy for primary central nervous system lymphoma. Neurosurg Focus 21: E12. Available at http://thejns.org/loi/foc
2. EM Bessell A Lopez-Guillermo S Villa E Verger B Nomdedeu J Petit P Byrne E Montserrat F Graus 2002 Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments J Clin Oncol 20 231 236 11773174 10.1200/JCO.20.1.231 1:STN:280:DC%2BD38%2FltFSntQ%3D%3D (Pubitemid 34032616)
3. M Reni AJ Ferreri N Guha-Thakurta JY Blay S Dell'Oro P Biron FH Hochberg 2001 Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate Int J Radiat Oncol Biol Phys 51 419 425 11567816 10.1016/S0360-3016(01)01639-X 1:CAS:528:DC%2BD3MXmvVyltbg%3D (Pubitemid 32884287)
4. LM DeAngelis JY Delattre JB Posner 1989 Radiation-induced dementia in patients cured of brain metastases Neurology 39 789 796 2725874 1:STN:280:DyaL1M3mt1Kisw%3D%3D (Pubitemid 19150153)
5. LE Abrey J Yahalom LM DeAngelis 2000 Treatment for primary CNS lymphoma: the next step J Clin Oncol 18 3144 3150 10963643 1:CAS:528:DC%2BD3cXntVCgsbs%3D
6. AM Omuro LS Ben-Porat KS Panageas AK Kim DD Correa J Yahalom LM Deangelis LE Abrey 2005 Delayed neurotoxicity in primary central nervous system lymphoma Arch Neurol 62 1595 1600 16216945 10.1001/archneur.62.10.1595 (Pubitemid 41434567)
7. AM Omuro LM DeAngelis J Yahalom LE Abrey 2005 Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up Neurology 64 69 74 15642906 10.1212/01.WNL.0000148641.98241.5E 1:CAS:528:DC%2BD2cXhtFeisr7K (Pubitemid 40082939)
8. T Batchelor K Carson A O'Neill SA Grossman J Alavi P New F Hochberg R Priet 2003 Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07 J Clin Oncol 21 1044 1049 12637469 10.1200/JCO.2003.03.036 1:CAS:528:DC%2BD2cXpsVGqsbc%3D (Pubitemid 46594133)
9. U Herrlinger W Kuker M Uhl HP Blaicher HO Karnath L Kanz M Bamberg M Weller 2005 NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report Ann Neurol 57 843 847 15929034 10.1002/ana.20495 1:CAS:528:DC%2BD2MXlslKks7w%3D (Pubitemid 40798622)
10. K Hoang-Xuan L Taillandier O Chinot P Soubeyran U Bogdhan J Hildebrand M Frenay N De Beule JY Delattre B Baron 2003 Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European organization for research and treatment of cancer brain tumor group J Clin Oncol 21 2726 2731 12860951 10.1200/JCO.2003.11.036 1:CAS:528:DC%2BD2cXptlCktb8%3D (Pubitemid 46606318)
11. H Pels IGH Schmidt-Wolf A Glasmacher H Schulz A Engert V Diehl A Zellner G Schackert H Reichmann F Kroschinsky M Vogt-Schaden G Egerer U Bode C Schaller M Deckert R Fimmers C Helmstaedter A Atasoy T Klockgether U Schlegel 2003 Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy J Clin Oncol 21 4489 4495 14597744 10.1200/JCO.2003.04.056 1:CAS:528: DC%2BD2cXpsVWqtbk%3D (Pubitemid 46594018)
12. V Sandor V Stark-Vancs D Pearson R Nussenblat SM Whitcup P Brouwers N Patronas J Heiss E Jaffe M deSmet D Kohler R Simon R Wittes 1998 Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma J Clin Oncol 16 3000 3006 9738568 1:CAS:528:DyaK1cXmtFSls7c%3D (Pubitemid 28417419)
13. AM Omuro L Taillandier O Chinot C Carnin M Barrie K Hoang-Xuan 2007 Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly J Neurooncol 85 207 211 17896079 10.1007/s11060-007-9397-0 1:CAS:528:DC%2BD2sXhtl2gs7rM (Pubitemid 47629402)
14. JJ Zhu ER Gerstner DA Engler MM Mrugala W Nugent K Nierenberg FH Hochberg RA Betensky TT Batchelor 2009 High-dose methotrexate for elderly patients with primary CNS lymphoma Neuro Oncology 11 211 215 18757775 10.1215/15228517-2008- 067 1:CAS:528:DC%2BD1MXkvFent7w%3D
15. LE Abrey TT Batchelor AJM Ferreri M Gospodarowicz EJ Pulczynski E Zucca JR Smith A Korfel C Soussain LM DeAngelis EA Neuwelt BP O'Neill E Thiel T Shenkier F Graus M van den Bent JF Seymour P Poortmans JO Armitage F Cavalli 2005 Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma J Clin Oncol 23 5034 5043 15955902 10.1200/JCO.2005.13.524 (Pubitemid 46224010)
16. C Soussain F Suzan K Hoang-Xuan N Cassoux V Levy N Azar C Belanger E Achour V Ribrag S Gerber JY Delattre V Leblond 2001 Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma J Clin Oncol 19 742 749 11157026 1:CAS:528:DC%2BD3MXhtlGrt74%3D (Pubitemid 32119089)
17. C Soussain K Hoang-Xuan L Taillandier E Fourme S Choquet F Witz O Casasnovas B Dupriez B Souleau AL Taksin C Gisselbrecht A Jaccard A Omuro M Sanson M Janvier B Kolb JM Zini V Leblond 2008 Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Societe Francaise de Greffe de Moelle Osseuse-Therapie Cellulaire J Clin Oncol 26 2512 2518 18413641 10.1200/JCO.2007.13.5533
18. A Juergens H Pels S Rogowski K Fliessbach A Glasmacher A Engert M Reiser V Diehl M Vogt-Schaden G Egerer G Schackert H Reichmann F Kroschinsky U Bode U Herrlinger M Linnebank M Deckert R Fimmers IG Schmidt-Wolf U Schlegel 2010 Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma Ann Neurol 67 182 189 20225195 10.1002/ana.21824 1:CAS:528:DC%2BC3cXksl2gu70%3D
19. H Pels A Juergens A Glasmacher H Schulz A Engert M Linnebank G Schackert H Reichmann F Kroschinsky M Vogt-Schaden G Egerer U Bode C Schaller M Lamprecht P Hau M Deckert R Fimmers C Bangard IG Schmidt-Wolf U Schlegel 2009 Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study J Neurooncol 91 299 305 18931887 10.1007/s11060-008-9712-4 1:CAS:528:DC%2BD1MXjvFemtA%3D%3D
20. M Ekenel FM Iwamoto LS Ben-Porat KS Panageas J Yahalom LM DeAngelis LE Abrey 2008 Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy Cancer 113 1025 1031 18618509 10.1002/cncr.23670 1:CAS:528:DC%2BD1cXhtFSlurrP
21. PL Nguyen A Chakravarti DM Finkelstein FH Hochberg TT Batchelor JS Loeffler 2005 Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma J Clin Oncol 23 1507 1513 15735126 10.1200/JCO.2005.01.161
22. AF Hottinger LM DeAngelis J Yahalom LE Abrey 2007 Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma Neurology 69 1178 1182 17846417 10.1212/01.wnl.0000276986.19602.c1 (Pubitemid 47517564)
23. E Thiel A Korfel P Martus L Kanz F Griesinger M Rauch A Roth B Hertenstein T von Toll T Hundsberger HG Mergenthaler M Leithauser T Birnbaum L Fischer K Jahnke U Herrlinger L Plasswilm T Nagele T Pietsch M Bamberg M Weller 2010 High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial Lancet Oncol 11 1036 1047 20970380 10.1016/S1470-2045(10)70229-1 1:CAS:528:DC%2BC3cXhtlKmtrnI
24. LE Abrey L Ben-Porat KS Panageas J Yahalom B Berkey W Curran C Schultz S Leibel D Nelson M Mehta LM DeAngelis 2006 Primary central nervous system lymphoma: the memorial Sloan-Kettering cancer center prognostic model J Clin Oncol 24 5711 5715 17116938 10.1200/JCO.2006.08.2941 (Pubitemid 46631313)
25. KR Lamborn WK Yung SM Chang PY Wen TF Cloughesy LM DeAngelis HI Robins FS Lieberman HA Fine KL Fink L Junck L Abrey MR Gilbert M Mehta JG Kuhn KD Aldape J Hibberts PM Peterson MD Prados 2008 Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas Neuro Oncology 10 162 170 18356283 10.1215/15228517-2007-062
26. A Silvani A Salmaggi M Eoli E Lamperti G Broggi CE Marras L Fariselli I Milanesi A Fiumani P Gaviani A Erbetta AR Giovagnoli B Pollo A Botturi A Boiardi 2007 Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience J Neurooncol 82 273 279 17111190 10.1007/s11060-006-9276-0 1:STN:280: DC%2BD2s3is1ymsw%3D%3D (Pubitemid 46614390)
27. G Illerhaus R Marks F Muller G Ihorst F Feuerhake M Deckert C Ostertag J Finke 2009 High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study Ann Oncol 20 319 325 18953065 10.1093/annonc/mdn628 1:STN:280: DC%2BD1M7jtlajtQ%3D%3D
28. GD Shah J Yahalom DD Correa RK Lai JJ Raizer D Schiff R LaRocca B Grant LM DeAngelis LE Abrey 2007 Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma J Clin Oncol 25 4730 4735 17947720 10.1200/JCO.2007.12.5062 1:CAS:528:DC%2BD2sXhtlCgsLnN (Pubitemid 350086474)
29. EA Neuwelt DL Goldman SA Dahlborg J Crossen F Ramsey S Roman-Goldstein R Braziel B Dana 1991 Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function J Clin Oncol 9 1580 1590 1875220 1:STN:280:DyaK3MzktFGhtg%3D%3D
30. LE Abrey CH Moskowitz WP Mason M Crump D Stewart P Forsyth N Paleologos DD Correa ND Anderson D Caron A Zelenetz SD Nimer LM DeAngelis 2003 Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis J Clin Oncol 21 4151 4156 14615443 10.1200/JCO.2003.05. 024 1:CAS:528:DC%2BD2cXpsVajtrs%3D (Pubitemid 46606183)
31. G Illerhaus F Muller F Feuerhake AO Schafer C Ostertag J Finke 2008 High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system Haematologica 93 147 148 18166803 10.3324/haematol.11771 1:CAS:528:DC%2BD1cXitVOhsLY%3D (Pubitemid 351156168)
32. JY Blay D Bouhour C Carrie E Bouffet M Brunat-Mentigny T Philip P Biron 1995 The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression Blood 86 2922 2929 7579384 1:CAS:528:DyaK2MXos1ynsrc%3D
33. IT Gavrilovic A Hormigo J Yahalom LM DeAngelis LE Abrey 2006 Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma J Clin Oncol 24 4570 4574 17008697 10.1200/JCO.2006.06.6910 1:CAS:528:DC%2BD28XhtFemtrbL (Pubitemid 46630953)
34. EM Bessell F Graus A Lopez-Guillermo S Villa E Verger J Petit I Holland P Byrne 2001 CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma Int J Radiat Oncol Biol Phys 50 457 464 11380234 10.1016/S0360-3016(01)01451-1 1:STN:280:DC%2BD3M3psF2ntQ%3D%3D (Pubitemid 32472275)
35. LM DeAngelis W Seiferheld SC Schold B Fisher CJ Schultz 2002 Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: radiation therapy oncology group study 93-10 J Clin Oncol 20 4643 4648 12488408 10.1200/JCO.2002.11.013 (Pubitemid 36025280)
36. G Illerhaus R Marks G Ihorst R Guttenberger C Ostertag G Derigs N Frickhofen F Feuerhake B Volk J Finke 2006 High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma J Clin Oncol 24 3865 3870 16864853 10.1200/JCO.2006.06.2117 1:CAS:528:DC%2BD28Xps1Sitr0%3D (Pubitemid 46630733)
37. P Colombat A Lemevel P Bertrand V Delwail P Rachieru A Brion C Berthou JO Bay R Delepine B Desablens S Camilleri-Broet C Linassier T Lamy 2006 High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group Bone Marrow Transpl 38 417 420 10.1038/sj.bmt.1705452 1:CAS:528:DC%2BD28XovF2ks7Y%3D (Pubitemid 44340371)